Moxifloxacino Reiwa Healthcare (Moxifloxacin)

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in various organ systems.

• Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms.
• Complicated skin and skin‑structure infections: resolves deep tissue infection and promotes wound healing.
• Intra‑abdominal infections: targets mixed aerobic and anaerobic bacteria to control intra‑abdominal sepsis.

• Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the unwinding and resealing of DNA strands, leading to bacterial cell death and a bactericidal effect against susceptible Gram‑positive and Gram‑negative organisms.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: loose stools, sometimes watery.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Rash: skin redness or itching.
• Elevated liver enzymes: mild hepatic enzyme increase.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or loss of function.
• QT interval prolongation: risk of cardiac arrhythmia.
• Severe allergic reactions: anaphylaxis, swelling, or breathing difficulty.
• Clostridioides difficile infection: severe colitis.
• Stevens‑Johnson syndrome: extensive skin blistering.
• Hepatic failure: marked liver dysfunction.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

• Assess renal function: adjust therapy if renal impairment is present.
• Monitor QT interval: avoid in patients with known prolonged QT or concurrent QT‑prolonging drugs.
• Avoid in patients with tendon disorders: risk of tendon rupture is increased.
• Use with caution in hepatic impairment: monitor liver enzymes regularly.
• Review concomitant medications: identify potential interactions.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Moxifloxacin can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Other fluoroquinolones: additive toxicity.
• QT‑prolonging agents (e.g., macrolides, antiarrhythmics): increased arrhythmia risk.
• Antacids containing aluminum or magnesium: reduced absorption.
• Warfarin: enhanced anticoagulant effect, monitor INR.
• Systemic corticosteroids: heightened tendon rupture risk.

Moderate Interactions (Monitor Closely)

• NSAIDs: potential for increased central nervous system effects.
• Oral hypoglycemics: may alter blood glucose control.
• Digoxin: possible increased serum levels.
• Theophylline: risk of elevated theophylline concentrations.
• Cyclosporine: may increase cyclosporine exposure.